Pages

▼
Showing posts with label Industry Trends. Show all posts
Showing posts with label Industry Trends. Show all posts
Tuesday, August 04, 2026

Who Will Pay for Prescription Drugs in 2034? Medicare's Surprising Rise in the Latest Government Forecasts

›
By Adam J. Fein, Ph.D. and Greis Kapexhiu In late June, the boffins at the Centers for Medicare & Medicaid Services (CMS) released the...
Tuesday, July 21, 2026

2025 Gross-to-Net Realities at Eight Top Drugmakers: The Net Pricing Drug Channel Emerges

›
By Adam J. Fein, Ph.D. Every year, Drug Channels reviews drug pricing trends at the largest pharmaceutical manufacturers. This year's...
Wednesday, July 15, 2026

The 340B Program Hit $100 Billion in 2025: Has It Become Too Big to Reform?

›
By Adam J. Fein, Ph.D. The 340B Drug Pricing Program continues to redefine the meaning of "skyrocketing." For 2025, discounted pu...
Tuesday, June 23, 2026

Pharmacist Salaries and Employment in 2025: Retail Declines, Hospital Gains

›
By Adam J. Fein, Ph.D. and Greis Kapexhiu It’s time for Drug Channels ’ annual look at pharmacist salaries and employment. The latest dat...
Tuesday, June 09, 2026

The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments (rerun)

›
This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles,...
Wednesday, May 20, 2026

PBM Shakeout: How Vertical Integration Is Reshaping What’s Next (VIDEO)

›
Here at Drug Channels , we’ve been closely tracking the evolution of the pharmacy benefit management (PBM) industry for many years. The sho...
Tuesday, May 12, 2026

340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar)

›
Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the editor of Drug Channels , for his latest exclusive video webinar: ...
Tuesday, May 05, 2026

Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point

›
By Adam J. Fein, Ph.D. The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Once again, the specialty pharmacy ...
Monday, March 30, 2026

The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments

›
By Adam J. Fein, Ph.D. Three is still the magic number for pharmacy benefit managers (PBMs). For 2025, 80% of all equivalent prescription c...
Tuesday, March 24, 2026

NOW AVAILABLE: The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

›
I am pleased to announce Drug Channels Institute’s new 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , now available...
Tuesday, March 17, 2026

The Top 15 U.S. Pharmacies of 2025: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies

›
By Adam J. Fein, Ph.D. Next week, the Drug Channels Institute (DCI) will release our 2026 Economic Report on U.S. Pharmacies and Pharmacy Be...
Tuesday, March 10, 2026

PBM Industry Update 2026: Trends, Challenges, and What’s Ahead (NEW Live Video Webinar)

›
Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the editor of Drug Channels , for his latest exclusive video webinar: ...
Tuesday, March 03, 2026

Preorder Now: DCI’s 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

›
On March 24, 2026, Drug Channels Institute will release The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers . This re...
Tuesday, February 03, 2026

Latest CMS Data Reveal Six Trends Reshaping U.S. Drug Spending

›
By Adam J. Fein, Ph.D. The boffins at the Centers for Medicare & Medicaid Services (CMS) recently dropped the latest National Health Exp...
Tuesday, January 13, 2026

NEW: The Drug Channels 2026 Video Webinar Series

›
Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI), for three new video webinars during 2026. These live, interactive events ...
Wednesday, January 07, 2026

U.S. Brand-Name Drug Prices Fell in 2025 as the Net Pricing Drug Channel Emerges

›
By Adam J. Fein, Ph.D. It's time for Drug Channels ’ annual examination of U.S. brand-name drug pricing. For 2025, brand-name drugs’ av...
Friday, December 12, 2025

Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: Drug Channels outlook 2026 . I'll be discuss...
Wednesday, December 10, 2025

Who Will Pay for Prescription Drugs in 2033: DCI’s Takeaways from the Latest Government Forecasts (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday's live video webinar: Drug Channels Outlook 2026 . Click here t...
Tuesday, November 18, 2025

Drug Channels News Roundup, November 2025: PBM Revolution, Cuban’s Stelara Challenge, Express Scripts’ Price Games, U.S. Drug Spending Reality, and the AFP Reckoning

›
By Adam J. Fein, Ph.D. Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with some fresh food for thought fr...
Wednesday, November 12, 2025

Drug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Part D, DTC Strategies, Drug Policy Trends, and More

›
2026 is shaping up to be another transformative year for the U.S. drug channel. Join Adam J. Fein , Ph.D. —president...